Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Safety and Efficacy of 10 mg, 30 mg, and 50 mg of Transnasal Ketamine Hydrochloride (PMI-100) for the Treatment of Postoperative Dental Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Ketamine (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Javelin Pharmaceuticals
- 05 Nov 2010 New trial record.